USG's announcement of an agreement to resolve asbestos personal injury claims should show the U.S. Senate once and for all exactly why S.852 is a boon to a handful of Fortune 50 companies and a death knell to smaller and medium-sized companies. It is rare that the financial benefits inherent in a piece of legislation for a single company are so clearly quantified -- no wonder companies like USG are spending millions of dollars on advertising to get this bill passed.
Tom O'Brien